Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Chem Biol. 2007 Dec;14(12):1323–1333. doi: 10.1016/j.chembiol.2007.10.016

Figure 5.

Figure 5

Mouse matrigel and chick chorioallantoic membrane angiogenesis assays. (A) Y341A mutation activated full-length TyrRS for angiogenesis in the mouse matrigel angiogenesis assay. The blood vessel content in the matrigel plug with PBS control was normalized to 1. Four mice were used for separate controls with PBS and VEGF and 6 mice were used for each of the TyrRS samples. Data show mean ± s.e.m. (B) Y341A mutation activated the full-length TyrRS for angiogenesis in chick chorioallantoic membrane angiogenesis assay. The plot shows mean of about 30 measurements for each sample ± s.e.m.